Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review.

Journal of child and adolescent psychopharmacology - 1 Apr 2007

Zuckerman Marcia L, Vaughan Brigid L, Whitney Jane, Dodds Alice, Yakhkind Aleksandra, MacMillan Carlene, Raches Darcy, Pravdova Iva, DeMaso David Ray, Beardslee William R, Gonzalez-Heydrich Joseph

Abstract excerpt

OBJECTIVE: To characterize the adverse effects of treatment with selective serotonin reuptake inhibitors (SSRIs) started in children under age 7 yr. METHODS: We conducted a retrospective review of medical records for all children who had begun treatment with an SSRI under age 7 at an academic psychiatry department in Boston. RESULTS: Thirty-nine children (26 males, 13 females) met the inclusion criteria. Mean age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Affective Symptoms
Share to Age Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aggression

Share to Child, Preschool

Share to Gastrointestinal Diseases

Share to Hyperkinesis

Share to Mental Disorders

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 17489711
DOI: 10.1089/cap.2007.0086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review.PMID 17489711Read ↗

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysisSemantic proximity Read ↗

Emergence of psychiatric adverse events during antipsychotic treatment in naive children and adolescentsSemantic proximity Read ↗

Audit of use of stiripentol in adults with Dravet syndrome.Semantic proximity Read ↗

Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and their Relationship to Treatment with Escitalopram or PlaceboSemantic proximity Read ↗

Medical management of pediatric mood disorders.Semantic proximity Read ↗

The side effects of levetiracetam monotherapy in pediatric epilepsy patientsSemantic proximity Read ↗

The effectiveness of using escitalopram in pediatric generalized anxiety disorder and the methods to predict the treatment response: A systematic review and meta-analysisSemantic proximity Read ↗

A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.Semantic proximity Read ↗

Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype.Semantic proximity Read ↗

Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype.Semantic proximity Read ↗

Clinical experience using intranasal ketamine in the longitudinal treatment of juvenile bipolar disorder with fear of harm phenotype.Semantic proximity Read ↗

Concerning harm/benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval processSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.